J. Kelly Ganjei, AmplifyBio CEO and president

Af­ter pri­vate and state in­vest­ment, Am­pli­fy­Bio plans to ex­pand to an­oth­er Colum­bus, OH lo­ca­tion

An Ohio-based biotech spin­out is gar­ner­ing even more in­vest­ment and space even af­ter on­ly be­ing around for about a year.

Am­pli­fy­Bio, a CRO and R&D biotech, has re­ceived a nine-fig­ure in­vest­ment to ex­pand its fa­cil­i­ties to a sec­ond lo­ca­tion in New Al­bany, a sub­urb of the state cap­i­tal of Colum­bus.

The com­pa­ny is re­ceiv­ing an in­vest­ment of around $150 mil­lion to es­tab­lish a new 350,000-square-foot fa­cil­i­ty. With this in­vest­ment, the com­pa­ny is al­so ex­pect­ed to cre­ate over 200 new jobs both at its new lo­ca­tion and at an ex­ist­ing lo­ca­tion in West Jef­fer­son, an­oth­er Colum­bus sub­urb. That lo­ca­tion, which has 220,000-square-feet of space for the young biotech, is the head­quar­ters for non­prof­it Bat­telle, which spun out Am­pli­fy­Bio last year.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.